IMBRUVICA
IMBRUVICA
Approved
DIN Number
02540215
Drug Class
Human
Market Date
Nov 13, 2023
Company
HC
Janssen Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02540215
AIG Number0156250005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EL01 IBRUTINIB
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
IBRUTINIBActive
Strength: 70 MG / ML
Monograph: IBRUTINIB